The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...
In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 ...
As President Donald Trump's escalating tariff policies threaten to raise costs across global supply chains, one pharmaceutical giant is taking steps to protect its bottom line. On ...
Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...
Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...
Clawbacks for the 2024 hospital pharmaceutical budget came in marginally lower than 2023’s critical levels, remaining at an ...
Besides the pharmaceutical industry, the Holy Father also criticized the influence of big tech in promoting unhealthy, ...
The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback